← TrialMatch
HomeTrials

Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.

Condition(s)Lower Limb Injury
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.
Who can participateInclusion Criteria: * Must be at least 18 years of age and younger than 65 years of age * ASA class I-II * Diagnosed with a lower limb extensor injury (quadriceps tendon rupture, patella tendon rupture, patella fracture) * Intention to receive physical therapy as standard of care Exclusion Criteria: * Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.) * Younger than 18 years of age or older than 65 * Any patient considered a vulnerable subject * Patients with impaired circulation, peripheral vascular compromise, previous revascularization of the extremity, or severe hypertension * Concomitant lower extremity traumatic injuries, delaying or precluding the subject's ability to participate in the therapy * Immobile or use of mobile assistive device pr
Ages18 Years to 65 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorNYU Langone Health
LocationsNew York, New York, United States
Start date2021-09-01
NCT IDNCT04149977
Official listinghttps://clinicaltrials.gov/study/NCT04149977

🔍 Search all trials →